CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $558,000 | +2.2% | 60,000 | +20.0% | 0.60% | -12.0% |
| Q4 2018 | $546,000 | -52.0% | 50,000 | -44.4% | 0.68% | -43.3% |
| Q3 2018 | $1,138,000 | +1.7% | 90,000 | +5.9% | 1.21% | +6.8% |
| Q2 2018 | $1,119,000 | +9.7% | 85,000 | +13.3% | 1.13% | -7.7% |
| Q1 2018 | $1,020,000 | +7.1% | 75,000 | -53.1% | 1.23% | +2.4% |
| Q4 2017 | $952,000 | -19.8% | 160,000 | 0.0% | 1.20% | -3.9% |
| Q3 2017 | $1,187,000 | -20.8% | 160,000 | 0.0% | 1.24% | -17.2% |
| Q2 2017 | $1,498,000 | +28.6% | 160,000 | 0.0% | 1.50% | +27.6% |
| Q1 2017 | $1,165,000 | +31.2% | 160,000 | +33.3% | 1.18% | +17.4% |
| Q4 2016 | $888,000 | +63.2% | 120,000 | +33.3% | 1.00% | +71.5% |
| Q3 2016 | $544,000 | -19.3% | 90,000 | -40.0% | 0.58% | -24.1% |
| Q2 2016 | $674,000 | – | 150,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |